Stories
Zabrina Watkins named diversity, equity, and inclusion director for Prime Therapeutics
March 28, 2022Prime Therapeutics (Prime) recently named Zabrina Watkins its new diversity, equity and inclusion (DEI) director.
“At Prime, we’re committed to fostering a culture of inclusion, where everyone feels they can belong and thrive,” said Watkins. “This year we published our first DEI transparency report, highlighting steps we’ve taken toward enhancing workplace inclusion and pledging to continue this important journey,” Watkins added.
Effective March 1, 2022, Watkins assumed the role to build on current and future DEI initiatives for Prime. At Prime, Watkins previously served as co-chair for Prime’s Diversity & Inclusion (D&I) Council and now serves on its Alumni Board. Watkins also currently serves as a lead for Prime’s Black Professionals + Allies employee resource group.
“I am humbled to take on the role of DEI director,” Watkins said. “And I look forward to continuing to build upon the solid foundation and framework for strategies, programs and initiatives that reinforce Prime’s commitment to a more equitable and inclusive organization.”
Prime’s commitment to diversity, equity and inclusion is rooted in its collective values as a company and inseparable from Prime’s purpose and dedication to serving others. Going forward, Prime will further its mission to champion DEI awareness, outreach and events, engaging its employees on a journey toward making workplace inclusion a part of its DNA.
Related news
Stories
May 2, 2024
Prime discusses leading medically integrated dispensing model at Asembia
Connecting specialty pharmacies and providers to unlock optimal care and value
Stories
April 30, 2024
RECAP: Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2024
Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024
Stories
April 24, 2024
New study conducted by Prime Therapeutics researchers offers insights into ways to increase equity in health care
Research published in the Journal of Managed Care & Specialty Pharmacy uses population data to fill gaps in social determinants of health data, providing a more complete understanding of a patient’s global health circumstances